The viral vector purification market has crossed a strategic threshold. The question is no longer whether demand for gene therapy and advanced vaccines will accelerate—it’s whether your organization has the intelligence infrastructure to act on that acceleration before competitors do. Market disruptions in bioprocessing have a history of accelerating structural shifts....